SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-23-000336
Filing Date
2023-06-05
Accepted
2023-06-05 17:00:18
Documents
1
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 FOR 05-25-2023 form_3.html 3  
1 FORM 3 FOR 05-25-2023 form_3.xml 3 2702
  Complete submission text file 0001161697-23-000336.txt   4360
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10975 N. TORREY PINES RD., SUITE 150 LA JOLLA CA 92037
Business Address
Thompson Tamar (Reporting) CIK: 0001839248 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 23993509